Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases
Volume 1, Issue 1, Pages 28-30
Case Report

Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant

H Amin, T Jadavji, R Sauve, and J Gill

Departments of Pediatrics, Microbiology and Infectious Disease. Foothills Hospital, The University of Calgary, Alberta, Canada

Received 23 January 1990; Accepted 19 April 1990

Copyright © 1990 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days was given without adverse clinical or toxic effects. The patient has remained well following discharge from hospital.